A clinical trial is a research study in which patients
participate to help determine the effectiveness of
a new medical treatment, procedure or technology. Our
Clinical Research program contributes to the development of
oncological therapies and advancements that result in a better
future for patients here, and around the world. “In the past five
to ten years, there has been tremendous progress in the field of
oncology research. The increasing number of breakthroughs
is enhancing care and treatment for an array of cancer types,”
remarked Mukul Gupta, MD, Ridley-Tree Cancer Center’s
director of the Clinical Research Department.
As part of our commitment to keeping the Central Coast
at the forefront of modern cancer care, Ridley-Tree Cancer
Center partners with US Oncology Research Network, TRIO-US
Network, leading pharmaceutical companies and universities.
Our new affiliation with the NRG Oncology Network, an NCI
funded collaborative, broadens our study portfolio adding
Radiation Oncology and Surgical Oncology studies to our
strong Medical Oncology pipeline, providing our patients
with access to clinical trials at Ridley-Tree Cancer Center.
Through these networks, we identify and initiate trials based
on the science and the need in our community. Currently,
we participate in 20 to 30 trials at any given time, spanning
diagnoses including breast cancer, lung cancer, lymphoma,
melanoma, prostate cancer, ovarian cancer and more.
Our oncologists work with members of the Clinical Research
Department to review patient records and identify those who
would benefit from the promising new therapies offered
in clinical trials. Implementation of these studies requires a
team of dedicated physician principal investigators, highlytrained research coordinators as well as regulatory and data
specialists. This team is recognized for their focus on patient
safety and personalized care, and they compassionately guide
patients through each step of their treatment.
The Clinical Research program at Ridley-Tree Cancer Center is
made possible thanks to generous support from the Cancer
Foundation of Santa Barbara.
Browse our current clinical trials
at ridleytreecc.org.
For any questions, call (805) 879-0643
or email research@ridleytreecc.org